The Technical Analyst
Select Language :
ASLAN Pharmaceuticals [ASLN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

ASLAN Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

ASLAN Pharmaceuticals is listed at the  Exchange

-3.89% $0.615

America/New_York / 28 mar 2024 @ 16:00


ASLAN Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 10.66 mill
EPS: -3.00
P/E: -0.210
Earnings Date: Mar 29, 2024
SharesOutstanding: 17.33 mill
Avg Daily Volume: 1.013 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/233/233/23
Revenuen/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.210 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.04x
Company: PE -0.210 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.382
(124.69%) $0.767
Date: 2024-03-29
Expected Trading Range (DAY)

$ 0.513 - 0.701

( +/- 15.48%)
ATR Model: 14 days

Forecast: 16:00 - $0.615

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.615
Forecast 2: 16:00 - $0.615
Forecast 3: 16:00 - $0.615
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.615 (-3.89% )
Volume 0.471 mill
Avg. Vol. 1.013 mill
% of Avg. Vol 46.49 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for ASLAN Pharmaceuticals Limited

Last 12 Months

Last 12 months chart data with high, low, open and close for ASLAN Pharmaceuticals Limited

RSI

Intraday RSI14 chart for ASLAN Pharmaceuticals Limited

Last 10 Buy & Sell Signals For ASLN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            ASLAN Pharmaceuticals Limited

ASLN

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

Last 10 Buy Signals

Date Signal @
SNBNBUSDMar 29 - 08:12616.51
POOLXUSDMar 29 - 08:165.22
FIDAUSDMar 29 - 08:17$0.539
DIAUSDMar 29 - 08:170.685
ZRXUSDMar 29 - 08:16$0.903
ROSEUSDMar 29 - 08:16$0.138
KNCUSDMar 29 - 08:16$0.896
ETHUSDMar 29 - 08:16$3 535.40
WETHUSDMar 29 - 08:143 549.26
WMNTUSDMar 29 - 08:131.167

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.